Changes to Acetaminophen Formulations May Disrupt Care, ASHP Tells FDA
7/2/2009
ASHP urged a Food and Drug Administration (FDA) advisory group to exercise caution before recommending reformulation of existing acetaminophen-containing product because such changes can affect patient safety and continuity of care.
|